Literature DB >> 21616169

Bionanotechnologies for treatment and diagnosis of Alzheimer's disease.

S Moein Moghimi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21616169     DOI： 10.1016/j.nano.2011.05.001

Source DB:  PubMed          Journal:  Nanomedicine        ISSN： 1549-9634            Impact factor:   5.307


× No keyword cloud information.
  4 in total

Review 1.  Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

Authors:  Javed Ahmad; Sohail Akhter; Md Rizwanullah; Mohammad Ahmed Khan; Lucie Pigeon; Richard T Addo; Nigel H Greig; Patrick Midoux; Chantal Pichon; Mohammad Amjad Kamal
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

2.  Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.

Authors:  Mohammad H El-Dakdouki; Jingguang Xia; David C Zhu; Herbert Kavunja; Jessica Grieshaber; Sandra O'Reilly; J Justin McCormick; Xuefei Huang
Journal:  ACS Appl Mater Interfaces       Date:  2013-12-12       Impact factor: 9.229

3.  Detection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosa.

Authors:  Andrea Buda; Sonia Facchin; Elisa Dassie; Elisabetta Casarin; Mark A Jepson; Helmut Neumann; Giorgia Hatem; Stefano Realdon; Renata D'Incà; Giacomo Carlo Sturniolo; Margherita Morpurgo
Journal:  Int J Nanomedicine       Date:  2015-01-08

4.  A noninvasive method to determine the fate of Fe(3)O(4) nanoparticles following intravenous injection using scanning SQUID biosusceptometry.

Authors:  Wei-Kung Tseng; Jen-Jie Chieh; Yi-Fan Yang; Chih-Kang Chiang; Yuh-Lien Chen; Shieh Yueh Yang; Herng-Er Horng; Hong-Chang Yang; Chau-Chung Wu
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.